Kim Wijkstrom

Chief Marketing Officer at Vanda Pharmaceuticals Inc.

Kim Wijkstrom

Kim Wijkstrom

Chief Marketing Officer at Vanda Pharmaceuticals Inc.

Biography

Joakim Wijkstrom occupies the position of Chief Marketing Officer for Vanda Pharmaceuticals, Inc.

Overview
RelSci Relationships

79

Relationships
RelSci Relationships are individuals Kim Wijkstrom likely has professional access to. A relationship does not necessarily indicate a personal connection.

President & Chief Executive Officer at Vanda Pharmaceuticals Inc.

Relationship likelihood: Strong

Chief Executive Officer at Clinical Development Capital LLC

Relationship likelihood: Strong

Benefit Plan Administrator at Vanda Pharmaceuticals Inc.

Relationship likelihood: Strong

Senior Vice President, General Counsel & Secretary at Vanda Pharmaceuticals Inc.

Relationship likelihood: Strong

Senior Vice President & Chief Commercial Officer at Vanda Pharmaceuticals Inc.

Relationship likelihood: Strong

Chief People Officer at Vanda Pharmaceuticals Inc.

Relationship likelihood: Average

Co-Founder & Head, Business Development at Vanda Pharmaceuticals Inc.

Relationship likelihood: Average

Director at Atterx BioTherapeutics

Relationship likelihood: Average

President & Chief Executive Officer at Aevi Genomic Medicine, Inc.

Relationship likelihood: Average

Limited Partner at Lead Edge Capital Management LLC

Relationship likelihood: Average

Paths to Kim Wijkstrom
Potential Connections via
Relationship Science
You
Kim Wijkstrom
Chief Marketing Officer at Vanda Pharmaceuticals Inc.
Career History
Senior Vice President Account Director
Prior

BBDO West, with offices in Los Angeles and San Francisco, is part of BBDO Worldwide, the third largest global agency brand, with worldwide billings of more than $12 billion.

Chief Marketing Officer
2019 - Current

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. It intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Public Holdings
Restricted data only for RelSci Professional users.
Other Affiliations

Kim Wijkstrom is affiliated with BBDO West, Inc., Vanda Pharmaceuticals Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Kim Wijkstrom. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Kim Wijkstrom's profile does not indicate a business or promotional relationship of any kind between RelSci and Kim Wijkstrom.